サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1695932

免疫血液学の世界市場：2034年までの市場の機会と戦略

Immunohematology Global Market Opportunities And Strategies To 2034

出版日
ページ情報
英文 282 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
免疫血液学の世界市場：2034年までの市場の機会と戦略
出版日: 2025年03月20日
発行: The Business Research Company
ページ情報: 英文 282 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の免疫血液学の市場規模は、2019年に20億9,615万米ドルとなりました。同市場は、CAGR3.00％以上で2024年まで成長しています。

血液疾患の有病率の上昇は、実績期間における免疫血液学市場の成長に貢献しました。血液疾患の有病率が上昇を続ける中、精密な血液型検査、クロスマッチング検査、スクリーニング検査に対する需要が拡大しています。免疫血液学は、血液型抗原や抗体を同定し、輸血や臓器移植における適合性を確保するために極めて重要です。この分野は輸血反応を最小限に抑える上で重要な役割を果たすため、安全な輸血をサポートする信頼性の高い免疫血液学製品やサービスの必要性が高まっています。例えば、米国を拠点とする国立公衆衛生機関である疾病対策予防センター（Centers for Disease Control and Prevention）が2024年4月に発表した報告書によると、貧血を主な診断として内科を受診した患者数は280万人、死亡者数は6,021人で、人口10万人当たりの死亡率は1.8人でした。したがって、血液疾患の有病率の上昇が免疫血液学市場の成長を牽引しました。

当レポートは、世界の免疫血液学市場について調査し、市場の概要とともに、製品別、技術別、疾患別、用途別、エンドユーザー別、地域・国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 表の一覧

第4章 図表一覧

第5章 レポートの構成

第6章 市場の特徴

  • 一般的な市場の定義
  • サマリー
  • 免疫血液学市場の定義とセグメンテーション
  • 製品別市場セグメンテーション
    • 分析装置とシステム
    • 試薬
  • 技術別市場セグメンテーション
    • バイオチップ
    • 赤血球磁化技術（Emt）
    • ジェルカード
    • マイクロプレート
    • ポリメラーゼ連鎖反応（PCR）
    • その他
  • 疾患病別市場セグメンテーション
    • 血液関連疾患
    • HIV（ヒト免疫不全ウイルス）
    • 肝炎
  • 用途別市場セグメンテーション
    • 輸血前検査
    • 免疫溶血の調査
    • 周産期検査
    • 血液型分類
    • 白血球と血小板の血清学
  • エンドユーザー別市場セグメンテーション
    • 血液バンク
    • 診断・参照検査室
    • 病院
    • 学術研究機関

第7章 主要な市場動向

  • 最先端の自動化を備えた次世代血液処理システム
  • 高度なマルチプレックス分析別血液検査プロセスの最適化

第8章 免疫血液学市場- マクロ経済シナリオ

第9章 世界市場の規模と成長

  • 市場規模
  • 市場成長実績、2019年～2024年
  • 市場成長予測、2024年～2029年、2034年

第10章 世界の免疫血液学市場セグメンテーション

  • 世界の免疫血液学市場、製品別セグメンテーション、実績および予測、2019年～2024年、2029年、2034年
  • 世界の免疫血液学市場、技術別セグメンテーション、実績および予測、2019年～2024年、2029年、2034年
  • 世界の免疫血液学市場、疾患別セグメンテーション、実績および予測、2019年～2024年、2029年予想、2034年予想
  • 世界の免疫血液学市場、用途別セグメンテーション、実績および予測、2019年～2024年、2029年予測、2034年予測
  • 世界の免疫血液学市場、エンドユーザー別セグメンテーション、実績および予測、2019年～2024年、2029年予想、2034年予想

第11章 免疫血液学市場、地域別および国別分析

  • 世界の免疫血液学市場、地域別、実績および予測、2019年～2024年、2029年予想、2034年予想
  • 世界の免疫血液学市場、国別、実績および予測、2019年～2024年、2029年予想、2034年予想

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • QuidelOrtho Corporation
  • Abbott Laboratories
  • Grifols SA
  • Bio-Rad Laboratories, Inc
  • Danaher Corporation（Beckman Coulter, Inc.）

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

第23章 機会と戦略

  • 2029年の世界の免疫血液学市場- 最も新しい機会を提供する国
  • 2029年の世界の免疫血液学市場- 最も新しい機会を提供するセグメント
  • 2029年の世界の免疫血液学市場- 成長戦略
    • 市場動向に基づく戦略
    • 競合戦略

第24章 免疫血液学市場、結論・提言

第25章 付録

目次
Product Code: o&s1521

Immunohematology refers to the branch of medicine and diagnostics that focuses on the study of blood group antigens and antibodies to ensure safe and effective blood transfusion and management of immune-mediated blood disorders. This field encompasses a range of diagnostic methods, devices and reagents used to analyze and identify blood types, detect antibodies and manage conditions related to the immune response involving blood cells.

The immunohematology market consists of sales, by entities (organizations, sole traders, or partnerships), of immunohematology that are utilized primarily when blood compatibility needs to be ensured, such as during pretransfusion testing, organ transplantation and investigation of immune-mediated hemolysis.

The global immunohematology market was valued at $2,096.15 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 3.00%.

Increasing Prevalence Of Blood Disorders

An increasing prevalence of blood disorders contributed to the growth of the immunohematology market in the historic period. As the prevalence of blood disorders continues to rise, the demand for precise blood typing, crossmatching and screening tests is expanding. Immunohematology is crucial for the identification of blood group antigens and antibodies, ensuring compatibility in blood transfusions and organ transplants. This field plays a vital role in minimizing transfusion reactions, thereby increasing the need for dependable immunohematology products and services to support safe transfusion practices. For instance, in April 2024, according to a report published by the Centers for Disease Control and Prevention, a US-based national public health agency, there were 2.8 million visits to physician offices for anemia as the primary diagnosis, with 6,021 deaths, resulting in a mortality rate of 1.8 deaths per 100,000 population. Therefore, the increasing prevalence of blood disorders drove the growth of the immunohematology market.

Optimizing Blood Testing Processes With Advanced Multiplex Analysis

Companies operating in the immunohematology market focus on transforming blood transfusion management with advanced multiplex analysis. This technology enables high-resolution analysis of blood samples, allowing for more comprehensive and accurate results while reducing the need for multiple individual tests. It optimizes the testing process by grouping various parameters in one step, improving the efficiency and throughput of blood testing. For instance, in June 2024, Innobiochips, a France-based biotechnology company, introduced Omnys, an advanced solution designed to optimize blood transfusion, grouping and testing processes. This innovative system significantly improves laboratory efficiency by enabling multiplex analysis with high-resolution testing of blood components, such as ABO (major blood group system) /D typing (Rh factor) and phenotyping, while reducing the number of wells required from 16 to just 4-6. The Omnys incorporates multiple patented technologies, streamlining operations, minimizing waste and reducing the carbon footprint associated with blood testing. A beta testing program for Omnys is scheduled to begin in early 2025, offering blood banks and healthcare institutions an opportunity to assess its integration into transfusion workflows.

The global immunohematology market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 36.89% of the total market in 2023.

Immunohematology Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global immunohematology market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for immunohematology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immunohematology market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider immunohematology market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by disease, by application and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the immunohematology market.
  • Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product, by technology, by disease, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for immunohematology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Analyzers And Systems; Reagents
  • 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (EMT); Gel Cards; Microplates; Polymerase Chain Reaction (PCR); Other Technologies
  • 3) By Disease: Blood-Related Diseases; HIV (Human Immunodeficiency Viruses); Hepatitis
  • 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
  • 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
  • Companies Mentioned: QuidelOrtho Corporation (Ortho-Clinical Diagnostics); Abbott Laboratories; Grifols S.A.; BIO-RAD LABORATORIES, INC.; Beckman Coulter Inc. (Danaher Corporation)
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; immunohematology indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Immunohematology - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Immunohematology Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Analyzers And Systems
    • 6.4.2 Reagents
  • 6.5 Market Segmentation By Technology
    • 6.5.1 Biochips
    • 6.5.2 Erythrocyte-Magnetized Technology (Emt)
    • 6.5.3 Gel Cards
    • 6.5.4 Microplates
    • 6.5.5 Polymerase Chain Reaction (PCR)
    • 6.5.6 Other Technologies
  • 6.6 Market Segmentation By Disease
    • 6.6.1 Blood-Related Diseases
    • 6.6.2 HIV (Human immunodeficiency viruses)
    • 6.6.3 Hepatitis
  • 6.7 Market Segmentation By Application
    • 6.7.1 Pretransfusion Testing
    • 6.7.2 Investigation Of Immune Hemolysis
    • 6.7.3 Perinatal Testing
    • 6.7.4 Blood Group Phenotyping
    • 6.7.5 Leucocyte And Platelet Serology
  • 6.8 Market Segmentation By End User
    • 6.8.1 Blood Banks
    • 6.8.2 Diagnostic And Reference Laboratories
    • 6.8.3 Hospitals
    • 6.8.4 Academic And Research Institutes

7 Major Market Trends

  • 7.1 Next-Generation Blood Processing System With Cutting-Edge Automation
  • 7.2 Optimizing Blood Testing Processes With Advanced Multiplex Analysis

8 Immunohematology Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Immunohematology Market
  • 8.2 Impact Of The War In Ukraine On The Immunohematology Market
  • 8.3 Impact Of High Inflation On The Immunohematology Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 9.2.1 Market Drivers 2019 - 2024
    • 9.2.2 Market Restraints 2019- 2024
  • 9.3 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
    • 9.3.1 Market Drivers 2024 - 2029
    • 9.3.2 Market Restraints 2024 - 2029

10 Global Immunohematology Market Segmentation

  • 10.1 Global Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Immunohematology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.3 Global Immunohematology Market, Segmentation By Disease, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.4 Global Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.5 Global Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Immunohematology Market, Regional and Country Analysis

  • 11.1 Global Immunohematology Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.2 Global Immunohematology Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.3 Asia-Pacific Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Asia-Pacific Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Asia-Pacific Immunohematology Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 China Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 China Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 India Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 India Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 Japan Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 Japan Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Australia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Australia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Indonesia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Indonesia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.29 South Korea Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.30 South Korea Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate tax structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.3 Western Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Western Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Western Europe Immunohematology Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 UK Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 UK Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.12 Germany Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.13 Germany Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.16 France Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.17 France Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.20 Italy Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.21 Italy Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.24 Spain Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.25 Spain Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Major companies
  • 14.2 Eastern Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.3 Eastern Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 Eastern Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 Eastern Europe Immunohematology Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.8 Russia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.9 Russia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.3 North America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 North America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 North America Immunohematology Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 USA Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 USA Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.13 Canada Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.14 Canada Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.3 South America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 South America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 South America Immunohematology Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.8 Brazil Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.9 Brazil Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Major Companies
  • 17.2 Middle East Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.3 Middle East Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Middle East Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 18.3 Africa Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 18.4 Africa Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 QuidelOrtho Corporation
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Abbott Laboratories
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Financial Overview
  • 19.4 Grifols S.A.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Bio-Rad Laboratories, Inc
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Danaher Corporation (Beckman Coulter, Inc.)
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Werfen S.A. Acquired Immucor, Inc. to Strengthen Specialized Diagnostics Portfolio
  • 22.2 Quidel Corporation And Ortho Clinical Diagnostics Merger Strengthens Global In Vitro Diagnostics Leadership

23 Opportunities And Strategies

  • 23.1 Global Immunohematology Market In 2029 - Countries Offering Most New Opportunities
  • 23.2 Global Immunohematology Market In 2029 - Segments Offering Most New Opportunities
  • 23.3 Global Immunohematology Market In 2029 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Immunohematology Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer